Боль в нижней части спины у взрослых: факторы риска, симптомы, тактика ведения

1. Nachemson A. Epidemiology and the economics of low back pain. In: Herkowits H, Dvorak J, Bell G, Nordin M, Grob D, editors. The Lumbar Spine. 3rd edition. Philadelphia, Pa, USA: Lippincott; 2004. 
2. Shiri R, Solovieva S, Husgafvel-Pursiainen K et al. The association between obesity and the prevalence of low back pain in young adults: the cardiovascular risk in young finns study. Am J Epidemiol 2008;167 (9): 1110–9. 
3. Strine TW, Hootman JM. US national prevalence and correlates of low back and neck pain among adults. Arth Car Res 2007; 57 (4): 656–65.
4. Cassidy JD, Carroll LJ, Côté P. The Saskatchewan health and back pain survey: the prevalence of low back pain and related disability in Saskatchewan adults. Spine 1998; 23 (17): 1860–7.
5. Waxman R, Tennant A, Helliwell P. A prospective follow-up study of low back pain in the community. Spine 2000; 25 (16): 2085–90.
6. Harreby M, Kjer J, Hesselsøe G., Neergaard K. Epidemiological aspects and risk factors for low back pain in 38-year-old men and women: a 25-year prospective cohort study of 640 school children. Eur Spine J 1996; 5 (5): 312–8.
7. Heliovaara M, Sievers K, Impivaara O et al. Descriptive epidemiology and public health aspects of low back pain. Ann Med 1989; 21 (5): 327–33.
8. Andersson GBJ. Epidemiological features of chronic low-back pain. Lancet 1999; 354 (9178): 581–5.
9. Louw QA, Morris LD, Grimmer-Somers K. The prevalence of low back pain in Africa: a systematic review. BMC Musculoskelet Dis 2007; 8: art. 105. 
10. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res 2007; 21 (3): 403–25.
11. Эрдес Ш.Ф., Дубинина Т.В., Галушко Е.А. Частота и характер болей в нижней части спины среди амбулаторных больных в г. Москве. Сообщение I. Науч.-практ. ревматология. 2006; 2: 12–20.
12. Hakala P, Rimpelä A, Salminen JJ et al. Back, neck, and shoulder pain in Finnish adolescents: national cross sectional surveys. Br Med J 2002; 325 (7367): 743–5. 
13. Shiri R, Karppinen J, Leino-Arjas P et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010; 171 (2): 135–54.
14. Breen AC, Carr E, Langworthy JE et al. Back pain outcomes in primary care following a practice improvement intervention: a prospective cohort study. BMC Musculoskelet Dis 2011; 12: 28. 
15. Harms MC, Peers CE, Chase D. Low back pain: what determines functional outcome at six months? An observational study. BMC Musculoskelet Dis 2010; 11: 236.
16. Craft RM, Mogil JS, Aloisi AM. Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain 2004; 8 (5): 397–411.
17. Khorsan R, Hawk C, Lisi AJ, Kizhakkeveettil A. Manipulative therapy for pregnancy and related conditions: A systematic review. Obstet Gyneco 2009; 64: 416–27. 
18. Diakow PRP, Gadsby TA, Gadsby JB et al. Back pain during pregnancy and labor. J Manipulative Physiol Ther 1991; 14: 116–8. 
19. Berg G, Hammar M, Moller-Nielsen J et al. Low back pain during pregnancy. Obstet Gynecol 1988; 71: 71–5.
20. Поворознюк В.В., Григорьева Н.В. Менопауза и костно-мышечная система. К.: ТМК, 2004.
21. Bener A, Alwash R, Gaber T, Lovasz G. Obesity and low back pain. Collegium Antropologicum 2003; 27 (1): 95–104. 
22. Ouédraogo DD, Ouédraogo V, Ouédraogo LT et al. Prevalence and factors associated with low back pain among hospital staff in Ouagadougou (Burkina Faso) Médecine Tropicale 2010; 70 (3): 277–80.
23. Leveille SG, Guralnik JM, Hochberg M et al. Low back pain and disability in older women: independent association with difficulty but not inability to perform daily activities. J Gerontol Series A 1999; 54 (10): 487–93.
24. Hartvigsen J, Christensen K, Frederiksen H. Back and neck pain exhibit many common features in old age: a population-based study of 4,486 danish twins 70–102 years of age. Spine 2004; 29 (5): 576–80.
25. Leboeuf-Yde C, Nielsen J, Kyvik KO et al. Pain in the lumbar, thoracic or cervical regions: do age and gender matter? A population-based study of 34,902 Danish twins 20–71 years of age. BMC Musculoskelet Dis 2009; 10: art. 39.
26. Biering-Sorensen F, Thomsen C. Medical, social and occupational history as risk indicators for low-back trouble in a general population. Spine 1986; 11 (7): 720–5. 
27. Croft PR, Rigby AS. Socioeconomic influences on back problems in the community in Britain. J Epidemiol Com Health 1994; 48 (2): 166–70. 
28. Frymoyer JW, Pope MH, Costanza MC et al. Epidemiologic studies of low-back pain. Spine 1980; 5 (5): 419–23. 
29. Müller CF, Monrad T, Biering-Sørensen F et al. The influence of previous low back trouble, general health, and working conditions on future sick-listing because of low back trouble: a 15-year follow-up study of risk indicators for self-reported sick-listing caused by low back trouble. Spine 1999; 24 (15): 1562–70.
30. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12 (3): 264–8.
31. Deyo RA, Bass JE. Lifestyle and low-back pain. The influence of smoking and obesity. Spine 1989; 14 (5): 501–6. 
32. Lake JK, Power C, Cole TJ. Back pain and obesity in the 1958 British birth cohortcause or effect? J Clin Epidemiol 2000; 53 (3): 245–50. 
33. Heuch I, Hagen K, Heuch I et al. The impact of body mass index on the prevalence of low back pain: the HUNT study. Spine 2010; 35 (7): 764–8.
34. Power C, Frank J, Hertzman C et al. Predictors of low back pain onset in a prospective British study. Am J Pub Health 2001; 91 (10): 1671–8. 
35. Heliovaara M, Makela M, Knekt P et al. Determinants of sciatica and low-back pain. Spine 1991; 16 (6): 608–14.
36. Liuke M, Solovieva S, Lamminen A et al. Disc degeneration of the lumbar spine in relation to overweight. Int J Obes 2005; 29 (8): 903–8.
37. Coole C, Watson PJ, Drummond A. Low back pain patients' experiences of work modifications; a qualitative study. BMC Musculoskel Dis 2010; 11: 277. 
38. Lambeek LC, Bosmans JE, Van Royen BJ et al. Effect of integrated care for sick listed patients with chronic low back pain: economic evaluation alongside a randomised controlled trial. BMJ 2010; 341: 6414. 
39. Bishop MD, Horn ME, George SZ, Robinson ME. Self-reported pain and disability outcomes from an endogenous model of muscular back pain. BMC Musculoskel Dis 2011; 12: 35.
40. Jarvik J, Deyo R. Diagnostic Evaluation of Low Back Pain with Emphasis on Imaging. Ann Int Med 2002; 137: 586–97.
41. Balagué F, Troussier B, Salminen JJ. Non-specific low back pain in children and adolescents: risk factors. Eur Spine J 1999; 8 (6): 429–38.
42. National Institute for Health and Clinical Excellence. URL: http://www.nice.org.uk/nicemedia/live/11887/44345/44345.pdf. 
43. Waddell G. The back pain revolution eds. by 2nd ed. Edinburgh: Elsevier, 2004. URL: www.elsevierhealth.com.
44. Эрдес Ш.Ф. и др. Неспецифическая боль в нижней части спины. Клинические рекомендации для участковых терапевтов и врачей общей практики. М.: КомплектСервис, 2008.
45. VanTulder M, Becker А, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): S169–S91.
46. Chou R, Qaseem A, Snow V. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Int Med 2007; 147: 478–91.
47. Rainsford K. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161–70. 
48. Rainsford K. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology 2006; 14 (3–4): 120–37.
49. Pohjolainen T, Jekunen A, Autio L et al. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine 2000; 25 (12): 1579–85.
50. Licker P, Pawlowski C, Friedrich I et al. Double-blind, randomised, multi-centre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodalac in patients suffering from osteoarthritis of the knee. Eur J Rheumatol Inflamm 1994; 14 (2): 29–38.
51. Huskisson E, Macciocchi A, Rahlfs V et al. Nimesulide versus diclofenac in the treatment of osteoarthritis of the hip or knee: an active controlled equivalence study. Curr Ther Res 1999; 60: 253–65.
52. Kriegel W, Korff K, Ehrlich J et al. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract 2001; 55 (8): 510–14. 
53. Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int J Clin Pract 2004; 144 (Suppl.): 27–32.
54. Conforti A, Leone R, Moretti U et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf 2001; 24: 1081–90. 
55. Bogduk N, McGuirk B. Medical management of acute and chronic low back pain. Anevidence-basedapproach. Pain Res Clin Manag 2002; 13: 1–24.
56. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М.: ГЭОТАР-Медиа, 2010.
57. Бадокин В.В. Применение нимесулида в ревматологической практике: фокус на безопасность. РМЖ. 2011; 31.

Н.В.Пизова

ФГБОУ ВО Ярославский государственный медицинский университет Минздрава России